… Influenza is a severe disease burden among all age groups. This study aimed to review
the efficacy of inactivated influenza vaccines with MF59 adjuvant and non-adjuvanted …

… -age children generally have the greatest risk of influenza … intradermal vaccines and 5
included both MF59-adjuvanted … to vaccine and possibly reduce clinical vaccine efficacy in some …

… influenza vaccines often produce modest immunogenic responses in … This systematic
review includes information from 21 studies that compared the effectiveness of MF59 adjuvanted …

… against any influenza, adults aged 65 years and older. … meta-analysis of VE of adjuvanted
trivalent influenza vaccine … Although adjuvanted influenza vaccines enhance immunogenicity, …

… of any design aimed to evaluate immunogenicity, vaccine efficacy, tolerability and safety of
… evaluate the effectiveness of influenza vaccines in this age-class. However, RCTs in this age-…

… MF59 and AS03 are OE adjuvants using biodegradable … found that influenza vaccine
effectiveness in healthy adults was … ), vaccine-related adverse events, study design, subject ages, …

… New adjuvants have been developed to improve the efficacy … adjuvants in this age group,
we decided to conduct a review … with the MF59-adjuvanted H1N1 influenza vaccine out of a …

… immunogenicity of influenza vaccines and understand their association with real-world vaccine
effectiveness (VE) between these two age groups. … , and the MF-59 adjuvant had patent …

… and immunogenicity of adjuvanted influenza vaccination in … vaccine efficacy of the
MF59-adjuvanted trivalent influenza … response compared with the healthy individuals. It was found …

… The other age group starts at either 24 or 36 months and … safety and immunogenicity data,
trivalent MF59 adjuvanted IIV has … for improving the efficacy of influenza vaccines in children. …